Diaceutics (LON:DXRX) Reaches New 1-Year High – Here’s What Happened

Diaceutics PLC (LON:DXRX)’s share price reached a new 52-week high during trading on Wednesday . The stock traded as high as GBX 151 ($1.88) and last traded at GBX 145.50 ($1.82), with a volume of 416157 shares changing hands. The stock had previously closed at GBX 137.50 ($1.72).

Wall Street Analyst Weigh In

A number of analysts have commented on the company. Canaccord Genuity Group reiterated a “buy” rating and issued a GBX 160 ($2.00) price objective on shares of Diaceutics in a research report on Tuesday, December 17th. Canaccord Genuity Group reiterated a “buy” rating and set a GBX 160 ($2.00) price target on shares of Diaceutics in a research note on Tuesday, December 17th.

Diaceutics Trading Up 5.8 %

The company has a debt-to-equity ratio of 2.93, a current ratio of 4.85 and a quick ratio of 9.92. The business’s 50 day simple moving average is GBX 121.38 and its 200 day simple moving average is GBX 126.26. The stock has a market cap of £122.90 million, a P/E ratio of -4,850.00 and a beta of 0.58.

Diaceutics Company Profile

At Diaceutics we believe that every patient should get the opportunity to receive the right test and the right therapy to positively impact their disease outcome. We provide the world’s leading pharma and biotech companies with an end-to-end commercialisation solution for precision medicines through data analytics, scientific and advisory services enabled by our platform DXRX – The Diagnostics Network®.